Trial · NCT04971226
Adverse events452
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 452
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Asciminib (All Asciminib) | 23 | 200 | |
| other | Anaemia | Blood and lymphatic system disorders | Imatinib | 26 | 99 | |
| other | Anaemia | Blood and lymphatic system disorders | 2nd Generation TKI | 23 | 102 | |
| other | Anaemia | Blood and lymphatic system disorders | All Comparators | 49 | 201 | |
| other | Leukopenia | Blood and lymphatic system disorders | Asciminib (All Asciminib) | 16 | 200 | |
| other | Leukopenia | Blood and lymphatic system disorders | Imatinib | 12 | 99 | |
| other | Leukopenia | Blood and lymphatic system disorders | 2nd Generation TKI | 7 | 102 | |
| other | Leukopenia | Blood and lymphatic system disorders | All Comparators | 19 | 201 | |
| other | Neutropenia | Blood and lymphatic system disorders | Asciminib (All Asciminib) | 21 | 200 | |
| other | Neutropenia | Blood and lymphatic system disorders | Imatinib | 15 | 99 | |
| other | Neutropenia | Blood and lymphatic system disorders | 2nd Generation TKI | 16 | 102 | |
| other | Neutropenia | Blood and lymphatic system disorders | All Comparators | 31 | 201 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Asciminib (All Asciminib) | 27 | 200 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Imatinib | 14 | 99 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | 2nd Generation TKI | 17 | 102 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | All Comparators | 31 | 201 | |
| other | Vertigo | Ear and labyrinth disorders | Asciminib (All Asciminib) | 1 | 200 | |
| other | Vertigo | Ear and labyrinth disorders | Imatinib | 5 | 99 | |
| other | Vertigo | Ear and labyrinth disorders | 2nd Generation TKI | 4 | 102 | |
| other | Vertigo | Ear and labyrinth disorders | All Comparators | 9 | 201 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04971226/events